Exchange: NASDAQ·Updated 01:05 PM EDT

CBLL News

News
all
press releases
Monday's ETF Movers: IHI, REMX
In trading on Monday, the iShares U.S. Medical Devices ETF is outperforming other ETFs, up about 1.6% on the day. Components of that ETF showing particular strength include shares of Procept Biorobotics, up about 6.5% and shares of Ceribell, up about 4.1% on the day. And under...
Nasdaq News: Markets
Monday's ETF Movers: IHI, REMX
In trading on Monday, the iShares U.S. Medical Devices ETF is outperforming other ETFs, up about 1.6% on the day. Components of that ETF showing particular strength include shares of Procept Biorobotics, up about 6.5% and shares of Ceribell, up about 4.1% on the day. And under...
Nasdaq News: Markets
More News
Here's What Key Metrics Tell Us About CeriBell, Inc. (CBLL) Q2 Earnings
Although the revenue and EPS for CeriBell, Inc. (CBLL) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Zacks
CeriBell, Inc. (CBLL) Reports Q2 Loss, Tops Revenue Estimates
CeriBell, Inc. (CBLL) delivered earnings and revenue surprises of -13.33% and +3.22%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
QuidelOrtho (QDEL) Surpasses Q2 Earnings and Revenue Estimates
QuidelOrtho (QDEL) delivered earnings and revenue surprises of +425.00% and +2.65%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Zimmer Biomet (ZBH) Q2 Earnings and Revenues Beat Estimates
Zimmer (ZBH) delivered earnings and revenue surprises of +2.99% and +2.25%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Is CeriBell, Inc. (CBLL) Among the Best Brain-Computer Interface Stocks to Buy?
Is CeriBell, Inc. (CBLL) Among the Best Brain-Computer Interface Stocks to Buy...
Yahoo! Finance: News
CeriBell, Inc. (CBLL) Reports Q1 Loss, Beats Revenue Estimates
CeriBell, Inc. (CBLL) delivered earnings and revenue surprises of -32.48% and +1.14%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Phibro Animal Health (PAHC) Q3 Earnings and Revenues Surpass Estimates
Phibro (PAHC) delivered earnings and revenue surprises of +5.92% and +6.26%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Insider Selling: CeriBell (NASDAQ:CBLL) CTO Sells 11,104 Shares of Stock
CeriBell, Inc. (NASDAQ:CBLL - Get Free Report) CTO Raymond Woo sold 11,104 shares of CeriBell stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $20.44, for a total value of $226,965.76. Following the sale, the chief technology officer directly owned 197,648...
MarketBeat
CeriBell (CBLL) Projected to Post Earnings on Monday
CeriBell (NASDAQ:CBLL) will be releasing its Q1 2026 earnings after the market closes on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-ceribell-stock...
MarketBeat

Advertisement|Remove ads.